JUNS JUPITER NEUROSC

NASDAQ
$1.24

JUPITER NEUROSC (JUNS) is expected to report earnings on February 15, 2027, before the market open.

JUPITER NEUROSC Reported Earnings
Monday, November 16, 2026 · 12:00 AM ET
Earnings Date
Feb 15
Monday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About JUPITER NEUROSC

Jupiter Neurosciences Inc. is a clinical-stage pharmaceutical company focused on treating neuroinflammation, with a current focus on CNS disorders and rare diseases. The Company's pipeline is focused broadly on CNS disorder and includes indications such as Alzheimer's Disease, Parkinson's Disease, Mucopolysaccharidoses Type I, Friedreich's Ataxia and MELAS. Jupiter Neurosciences Inc. is based in Jupiter, Florida.

Charts powered in part by Lightweight Charts™ by TradingView.